Skip to content

US · PETS · SPECIALTY RETAIL

PetMed Express, Inc. (PETS) intrinsic value and stock valuation

$0.85as of 2026-11-21 · Mkt cap 42.1M

Data updated · price as of 2026-11-21

IC valuationIntrinsic value, upside vs price and the fair-value band are available to Pro members.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

PetMed Express, Inc. DCF and intrinsic value

InvestorsCraft values PETS with the Chepakovich two-stage DCF model. How the model works · Run your own DCF prefilled from PETS’s statements →

PetMed Express, Inc. Graham Number

The Graham Number is not defined for negative earnings or book value. Guide · Calculator →

Consumer Cyclical · Specialty Retail Delray Beach, FL 33445 1800petmeds.com

How the business is doing

Fiscal 2012–2026, USD

Revenue
$179M-10% 5y CAGRd
20122026
Net income
-$-57.29M
20122026
Free cash flow
-$-33.01M
20122026
Total equity
$28.9M-27.2% 5y CAGRd
20122026

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2012–2026, USD
20262025202420232022
Revenue$179M$227M$274.1M$256.6M$273.4M
Operating income-$-31.41M-$-1.53M-$-6.96M$6.55M$25.7M
Net income-$-57.29M-$-6.27M-$-7.46M$5.14M$21.1M
EPSd-$-2.74M-$-304.37K-$-365.69K$252.7K$1.04M
Operating cash flow-$-28.39M$4.72M$4.32M$27.8M$18.5M
Capital expenditure-$-4.62M-$-5.11M-$-4.51M-$-5.26M-$-1.75M
Free cash flow-$-33.01M-$-400K-$-190K$22.5M$16.8M
Total assets$81.2M$148.7M$169.9M$170M$176.3M
Total debt$540K$1M$1.45M$990K$0.00
Net debt-$-20.88M-$-53.72M-$-53.84M-$-103.09M-$-111.08M
Total equity$28.9M$85.1M$96.7M$110M$142.2M
Cash and short-term investments$21.4M$54.7M$55.3M$104.1M$111.1M
Income statement
20262025202420232022
Revenue$179M$227M$274.1M$256.6M$273.4M
Cost of revenue$138.2M$157.8M$196.4M$185.8M$198.1M
Gross profit$40.8M$69.1M$77.7M$71M$75.3M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$72.2M$62.4M$79.8M$68.9M$49.6M
Other expenses$0.00$8.24M$4.92M-$-4.21M$0.00
Operating expenses$72.2M$70.7M$84.7M$64.7M$49.6M
Cost and expenses$210.4M$228.5M$281.1M$250M$247.7M
Interest income$510K$0.00$510K$450K$340K
Interest expense$0.00$0.00$0.00$0.00$0.00
Depreciation and amortization$9.39M$7.04M$7.06M$3.55M$2.74M
Ebitda-$-22.03M$6.71M$780K$11M$29.8M
Operating income-$-31.41M-$-1.53M-$-6.96M$6.55M$25.7M
Total other income/expenses, net-$-25.94M$940K$690K$890K$1.36M
Income before tax-$-57.36M-$-590K-$-6.27M$7.45M$27.1M
Income tax expense-$-70K$5.68M$1.19M$2.31M$5.97M
Net income-$-57.29M-$-6.27M-$-7.46M$5.14M$21.1M
Weighted average shares outstanding$20.9M$20.6M$20.4M$20.3M$20.2M
Weighted average diluted shares outstanding$20.9M$20.6M$20.4M$20.3M$20.4M
Balance sheet
20262025202420232022
Cash and short-term investments$21.4M$54.7M$55.3M$104.1M$111.1M
Net receivables$1.91M$2.32M$3.28M$1.74M$1.91M
Inventory$13.6M$16.2M$28.6M$19M$32.5M
Total current assets$43.6M$78.9M$93.7M$130.4M$151M
Property, plant and equipment, net$26.8M$29.8M$28.1M$26.2M$24.5M
Goodwill and intangible assets$10.8M$40M$37.9M$5.86M$860K
Long-term investments$5.3M$0.00$5.3M$5M$24.3M
Total non-current assets$37.6M$69.8M$76.2M$39.6M$25.3M
Total assets$81.2M$148.7M$169.9M$170M$176.3M
Accounts payable$20.9M$23.6M$37M$25.2M$27.5M
Short-term debt$490K$460K$460K$0.00$0.00
Deferred revenue$690K$2.08M$2.6M$0.00$0.00
Total current liabilities$52M$62.8M$72.2M$57.5M$33.2M
Long-term debt$40K$540K$990K$990K$0.00
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$220K$800K$990K$2.53M$940K
Capital lease obligations$40K$0.00$990K$990K$0.00
Total liabilities$52.3M$63.6M$73.2M$60M$34.1M
Common stock$20K$20K$20K$20K$20K
Retained earnings$9.26M$66.5M$71.6M$91.7M$130.5M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$28.9M$85.1M$96.7M$110M$142.2M
Total investments$5.3M$0.00$5.3M$5M$24.3M
Total debt$540K$1M$1.45M$990K$0.00
Net debt-$-20.88M-$-53.72M-$-53.84M-$-103.09M-$-111.08M
Cash flow statement
20262025202420232022
Net income-$-57.29M-$-6.27M-$-7.46M$230K$21.1M
Depreciation and amortization$9.39M$7.04M$7.06M$3.55M$2.74M
Stock-based compensation$1.36M-$-6.59M$6.87M$6.62M$4.55M
Change in working capital-$-8.39M$3.72M-$-2.76M$13.9M-$-9.71M
Accounts receivable$450K$600K-$-1.74M-$-40K$510K
Inventory$470K$12.4M-$-6.42M$13.4M$1.97M
Accounts payable-$-2.66M-$-13.46M$6.1M-$-2.29M-$-12.05M
Net cash provided by operating activities-$-28.39M$4.72M$4.32M$27.8M$18.5M
Investments in property, plant and equipment-$-4.62M-$-5.11M-$-4.51M-$-5.26M-$-1.75M
Acquisitions, net$0.00$0.00-$-36.16M-$-5M$0.00
Net cash used for investing activities-$-4.62M-$-5.11M-$-40.67M-$-10.26M-$-1.75M
Common stock issued$0.00$0.00$0.00$0.00$0.00
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid-$-20K-$-180K-$-12.44M-$-24.54M-$-24.38M
Net cash used for financing activities-$-300K-$-180K-$-12.44M-$-24.54M-$-24.38M
Net change in cash-$-33.31M-$-580K-$-48.79M-$-6.99M-$-7.64M
Cash at end of period$21.4M$54.7M$55.3M$104.1M$111.1M
Operating cash flow-$-28.39M$4.72M$4.32M$27.8M$18.5M
Capital expenditure-$-4.62M-$-5.11M-$-4.51M-$-5.26M-$-1.75M
Free cash flow-$-33.01M-$-400K-$-190K$22.5M$16.8M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About PetMed Express, Inc.

        PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.

        CEO
        Leslie C. G. Campbell
        Employees
        189
        Beta
        0.78

        Included in

        Explore

        Frequently asked questions

        What is the intrinsic value of PetMed Express, Inc. (PETS)?

        InvestorsCraft does not currently publish an intrinsic value for PETS. How the IC value is calculated.

        Is PETS undervalued?

        InvestorsCraft does not publish an undervaluation signal for PETS at this time.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.